Egypt Hypertension Study

Study identifier:D1843R00249

ClinicalTrials.gov identifier:NCT02604771

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An epidemiological study to evaluate standard daily practice in managing patients with arterial hypertension

Medical condition

Different classes of the antihypertensive treatment

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1500

Study type

Observational

Age

N/A

Date

Study Start Date: 03 Apr 2016
Primary Completion Date: 14 Feb 2018
Study Completion Date: 14 Feb 2018

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2019 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria